Immunovant (NASDAQ: IMVT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Immunovant (NASDAQ: IMVT) through any online brokerage.
The latest price target for Immunovant (NASDAQ: IMVT) was reported by Wells Fargo on Wednesday, December 8, 2021. The analyst firm set a price target for 9.00 expecting IMVT to rise to within 12 months (a possible 115.83% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Immunovant (NASDAQ: IMVT) is $4.17 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Immunovant.
Immunovant’s Q1 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Immunovant.
Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.